Medical Care
Global Soliris (Eculizumab) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jul 08, 25
- ID: 353041
- Pages: 106
- Figures: 101
- Views: 14
In 2024, the global market size of Soliris (Eculizumab) was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Soliris (Eculizumab), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soliris (Eculizumab).
The Soliris (Eculizumab) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soliris (Eculizumab) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soliris (Eculizumab) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Alexion
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Soliris (Eculizumab) in global and regional level.
Chapter 3: Detailed analysis of Soliris (Eculizumab) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Soliris (Eculizumab) revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Soliris (Eculizumab), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soliris (Eculizumab).
The Soliris (Eculizumab) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soliris (Eculizumab) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soliris (Eculizumab) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Alexion
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Soliris (Eculizumab) in global and regional level.
Chapter 3: Detailed analysis of Soliris (Eculizumab) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Soliris (Eculizumab) revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Soliris (Eculizumab) Product Introduction
1.2 Market by Type
1.2.1 Global Soliris (Eculizumab) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Market by Application
1.3.1 Global Soliris (Eculizumab) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 PNH
1.3.3 aHUS
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Soliris (Eculizumab) Market Size Estimates and Forecasts
2.2 Soliris (Eculizumab) Market Size by Region: 2024 Versus 2031
2.2.1 Global Soliris (Eculizumab) Revenue by Region: 2020-2025
2.2.2 Global Soliris (Eculizumab) Revenue Forecast by Region (2026-2031)
2.2.3 Global Soliris (Eculizumab) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Soliris (Eculizumab) Revenue by Type (2020-2031)
3.1.2 Global Soliris (Eculizumab) Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Soliris (Eculizumab) Revenue by Application (2020-2031)
3.2.2 Global Soliris (Eculizumab) Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Plasma Exchange of Soliris (Eculizumab) Revenue Market Share by Application
3.3.2 Plasma Infusion of Soliris (Eculizumab) Revenue Market Share by Application
4 Global Soliris (Eculizumab) by Company
4.1 Global Soliris (Eculizumab) Revenue by Company (2020-2025)
4.2 Global Soliris (Eculizumab) Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Soliris (Eculizumab) Companies around the World: Ranking by Revenue
4.3.2 Global Soliris (Eculizumab) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Soliris (Eculizumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Soliris (Eculizumab) Companies Headquarters & Product Type
4.4.1 Global Soliris (Eculizumab) Companies Headquarters
4.4.2 Date of International Companies Enter into Soliris (Eculizumab) Market
4.4.3 Global Soliris (Eculizumab) Companies Product & Service
4.4.4 Plasma Exchange Revenue Market Share of Soliris (Eculizumab) by Company
4.5 Global Soliris (Eculizumab) Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Alexion
5.1.1 Alexion Corporation Information
5.1.2 Alexion Description, Business Overview
5.1.3 Alexion Soliris (Eculizumab) Products Offered
5.1.4 Alexion Soliris (Eculizumab) Revenue and Gross Margin (2020-2025)
5.1.5 Alexion Soliris (Eculizumab) Revenue by Product in 2024
5.1.6 Alexion Soliris (Eculizumab) Revenue by Application in 2024
5.1.7 Alexion Soliris (Eculizumab) Revenue by Geographic Area in 2024
5.1.8 Alexion Recent Developments
6 North America
6.1 North America Soliris (Eculizumab) Market Size YoY Growth 2020-2031
6.2 North America Soliris (Eculizumab) Market Facts & Figures by Country (2020-2031)
6.3 North America Soliris (Eculizumab) Revenue by Type (2020-2025)
6.4 North America Soliris (Eculizumab) Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Soliris (Eculizumab) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Soliris (Eculizumab) Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Soliris (Eculizumab) Revenue by Type (2020-2025)
7.4 Asia-Pacific Soliris (Eculizumab) Revenue by Application (2020-2025)
8 Europe
8.1 Europe Soliris (Eculizumab) Market Size YoY Growth 2020-2031
8.2 Europe Soliris (Eculizumab) Market Facts & Figures by Country (2020-2031)
8.3 Europe Soliris (Eculizumab) Revenue by Type (2020-2025)
8.4 Europe Soliris (Eculizumab) Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Soliris (Eculizumab) Market Size YoY Growth 2020-2031
9.2 Latin America Soliris (Eculizumab) Market Facts & Figures by Country (2020-2031)
9.3 Latin America Soliris (Eculizumab) Revenue by Type (2020-2025)
9.4 Latin America Soliris (Eculizumab) Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Soliris (Eculizumab) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Soliris (Eculizumab) Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Soliris (Eculizumab) Revenue by Type (2020-2025)
10.4 Middle East and Africa Soliris (Eculizumab) Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Soliris (Eculizumab) Supply Chain Analysis
11.2 Soliris (Eculizumab) Key Raw Materials and Upstream Suppliers
11.3 Soliris (Eculizumab) Clients Analysis
11.4 Soliris (Eculizumab) Sales Channel and Sales Model Analysis
11.4.1 Soliris (Eculizumab) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Soliris (Eculizumab) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Soliris (Eculizumab) Distributors
12 Soliris (Eculizumab) Market Dynamics
12.1 Soliris (Eculizumab) Industry Trends
12.2 Soliris (Eculizumab) Market Drivers
12.3 Soliris (Eculizumab) Market Challenges
12.4 Soliris (Eculizumab) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Soliris (Eculizumab) Product Introduction
1.2 Market by Type
1.2.1 Global Soliris (Eculizumab) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Market by Application
1.3.1 Global Soliris (Eculizumab) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 PNH
1.3.3 aHUS
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Soliris (Eculizumab) Market Size Estimates and Forecasts
2.2 Soliris (Eculizumab) Market Size by Region: 2024 Versus 2031
2.2.1 Global Soliris (Eculizumab) Revenue by Region: 2020-2025
2.2.2 Global Soliris (Eculizumab) Revenue Forecast by Region (2026-2031)
2.2.3 Global Soliris (Eculizumab) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Soliris (Eculizumab) Revenue by Type (2020-2031)
3.1.2 Global Soliris (Eculizumab) Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Soliris (Eculizumab) Revenue by Application (2020-2031)
3.2.2 Global Soliris (Eculizumab) Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Plasma Exchange of Soliris (Eculizumab) Revenue Market Share by Application
3.3.2 Plasma Infusion of Soliris (Eculizumab) Revenue Market Share by Application
4 Global Soliris (Eculizumab) by Company
4.1 Global Soliris (Eculizumab) Revenue by Company (2020-2025)
4.2 Global Soliris (Eculizumab) Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Soliris (Eculizumab) Companies around the World: Ranking by Revenue
4.3.2 Global Soliris (Eculizumab) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Soliris (Eculizumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Soliris (Eculizumab) Companies Headquarters & Product Type
4.4.1 Global Soliris (Eculizumab) Companies Headquarters
4.4.2 Date of International Companies Enter into Soliris (Eculizumab) Market
4.4.3 Global Soliris (Eculizumab) Companies Product & Service
4.4.4 Plasma Exchange Revenue Market Share of Soliris (Eculizumab) by Company
4.5 Global Soliris (Eculizumab) Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Alexion
5.1.1 Alexion Corporation Information
5.1.2 Alexion Description, Business Overview
5.1.3 Alexion Soliris (Eculizumab) Products Offered
5.1.4 Alexion Soliris (Eculizumab) Revenue and Gross Margin (2020-2025)
5.1.5 Alexion Soliris (Eculizumab) Revenue by Product in 2024
5.1.6 Alexion Soliris (Eculizumab) Revenue by Application in 2024
5.1.7 Alexion Soliris (Eculizumab) Revenue by Geographic Area in 2024
5.1.8 Alexion Recent Developments
6 North America
6.1 North America Soliris (Eculizumab) Market Size YoY Growth 2020-2031
6.2 North America Soliris (Eculizumab) Market Facts & Figures by Country (2020-2031)
6.3 North America Soliris (Eculizumab) Revenue by Type (2020-2025)
6.4 North America Soliris (Eculizumab) Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Soliris (Eculizumab) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Soliris (Eculizumab) Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Soliris (Eculizumab) Revenue by Type (2020-2025)
7.4 Asia-Pacific Soliris (Eculizumab) Revenue by Application (2020-2025)
8 Europe
8.1 Europe Soliris (Eculizumab) Market Size YoY Growth 2020-2031
8.2 Europe Soliris (Eculizumab) Market Facts & Figures by Country (2020-2031)
8.3 Europe Soliris (Eculizumab) Revenue by Type (2020-2025)
8.4 Europe Soliris (Eculizumab) Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Soliris (Eculizumab) Market Size YoY Growth 2020-2031
9.2 Latin America Soliris (Eculizumab) Market Facts & Figures by Country (2020-2031)
9.3 Latin America Soliris (Eculizumab) Revenue by Type (2020-2025)
9.4 Latin America Soliris (Eculizumab) Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Soliris (Eculizumab) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Soliris (Eculizumab) Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Soliris (Eculizumab) Revenue by Type (2020-2025)
10.4 Middle East and Africa Soliris (Eculizumab) Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Soliris (Eculizumab) Supply Chain Analysis
11.2 Soliris (Eculizumab) Key Raw Materials and Upstream Suppliers
11.3 Soliris (Eculizumab) Clients Analysis
11.4 Soliris (Eculizumab) Sales Channel and Sales Model Analysis
11.4.1 Soliris (Eculizumab) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Soliris (Eculizumab) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Soliris (Eculizumab) Distributors
12 Soliris (Eculizumab) Market Dynamics
12.1 Soliris (Eculizumab) Industry Trends
12.2 Soliris (Eculizumab) Market Drivers
12.3 Soliris (Eculizumab) Market Challenges
12.4 Soliris (Eculizumab) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Soliris (Eculizumab) Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Soliris (Eculizumab) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Soliris (Eculizumab) Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Soliris (Eculizumab) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Soliris (Eculizumab) Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Soliris (Eculizumab) Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Soliris (Eculizumab) Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Soliris (Eculizumab) Revenue by Company (2020-2025) & (US$ Million)
Table 11. Soliris (Eculizumab) Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Soliris (Eculizumab) Players by Revenue (US$ Million) in 2024
Table 13. Global Soliris (Eculizumab) Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Soliris (Eculizumab) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris (Eculizumab) as of 2024)
Table 15. Global Soliris (Eculizumab) Companies Headquarters
Table 16. Date of International Companies Enter into Soliris (Eculizumab) Market
Table 17. Global Soliris (Eculizumab) Companies Product & Service
Table 18. Global Soliris (Eculizumab) Mergers & Acquisitions, Expansion Plans
Table 19. Alexion Corporation Information
Table 20. Alexion Description and Business Overview
Table 21. Alexion Soliris (Eculizumab) Product
Table 22. Alexion Soliris (Eculizumab) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Alexion Revenue Proportion of Soliris (Eculizumab) by Product in 2024
Table 24. Alexion Revenue Proportion of Soliris (Eculizumab) by Application in 2024
Table 25. Alexion Revenue Proportion of Soliris (Eculizumab) by Geographic Area in 2024
Table 26. Alexion Recent Developments
Table 27. North America Soliris (Eculizumab) Revenue by Country (2020-2025) & (US$ Million)
Table 28. North America Soliris (Eculizumab) Revenue by Country (2026-2031) & (US$ Million)
Table 29. North America Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 30. North America Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 31. Asia-Pacific Soliris (Eculizumab) Revenue by Region (2020-2025) & (US$ Million)
Table 32. Asia-Pacific Soliris (Eculizumab) Revenue by Region (2026-2031) & (US$ Million)
Table 33. Asia-Pacific Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 34. Asia-Pacific Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 35. Europe Soliris (Eculizumab) Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Soliris (Eculizumab) Revenue by Country (2026-2031) & (US$ Million)
Table 37. Europe Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 38. Europe Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 39. Latin America Soliris (Eculizumab) Revenue by Country (2020-2025) & (US$ Million)
Table 40. Latin America Soliris (Eculizumab) Revenue by Country (2026-2031) & (US$ Million)
Table 41. Latin America Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 42. Latin America Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 43. Middle East and Africa Soliris (Eculizumab) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Middle East and Africa Soliris (Eculizumab) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 46. Middle East and Africa Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 47. Soliris (Eculizumab) Key Raw Materials, Industry Status and Trend
Table 48. Soliris (Eculizumab) Key Raw Materials and Upstream Suppliers
Table 49. Soliris (Eculizumab) Clients Status and Trend
Table 50. Soliris (Eculizumab) Typical Clients
Table 51. Soliris (Eculizumab) Distributors
Table 52. Soliris (Eculizumab) Market Trends
Table 53. Soliris (Eculizumab) Market Drivers
Table 54. Soliris (Eculizumab) Market Challenges
Table 55. Soliris (Eculizumab) Market Restraints
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Soliris (Eculizumab) Product Picture
Figure 2. Global Soliris (Eculizumab) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Soliris (Eculizumab) Revenue Market Share by Type in 2024 & 2031
Figure 4. Plasma Exchange Product Picture
Figure 5. Plasma Infusion Product Picture
Figure 6. Global Soliris (Eculizumab) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Soliris (Eculizumab) Revenue Market Share by Application in 2024 & 2031
Figure 8. PNH
Figure 9. aHUS
Figure 10. Others
Figure 11. Soliris (Eculizumab) Report Years Considered
Figure 12. Global Soliris (Eculizumab) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Soliris (Eculizumab) Market Size (2020-2031) & (US$ Million)
Figure 14. Global Soliris (Eculizumab) Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Soliris (Eculizumab) Revenue Market Share by Region (2020-2031)
Figure 16. Global Soliris (Eculizumab) Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Soliris (Eculizumab) Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Plasma Exchange of Soliris (Eculizumab) Revenue Market Share by Application, 2024 VS 2031
Figure 19. Plasma Infusion of Soliris (Eculizumab) Revenue Market Share by Application, 2024 VS 2031
Figure 20. Soliris (Eculizumab) Revenue Share by Company (2024)
Figure 21. Soliris (Eculizumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Plasma Exchange Revenue Proportion by Company in 2024
Figure 23. Plasma Infusion Revenue Proportion by Company in 2024
Figure 24. North America Soliris (Eculizumab) Revenue 2020-2031 (US$ Million)
Figure 25. North America Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 26. North America Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Soliris (Eculizumab) Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Soliris (Eculizumab) Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 31. Europe Soliris (Eculizumab) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Soliris (Eculizumab) Revenue Market Share by Country (2020-2031)
Figure 33. Europe Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 34. Europe Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Soliris (Eculizumab) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Soliris (Eculizumab) Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Soliris (Eculizumab) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 43. Soliris (Eculizumab) Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Soliris (Eculizumab) Raw Materials by Region in 2024
Figure 45. Soliris (Eculizumab) Distribution Channels
Figure 46. Global Soliris (Eculizumab) Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Soliris (Eculizumab) Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Soliris (Eculizumab) Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Soliris (Eculizumab) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Soliris (Eculizumab) Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Soliris (Eculizumab) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Soliris (Eculizumab) Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Soliris (Eculizumab) Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Soliris (Eculizumab) Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Soliris (Eculizumab) Revenue by Company (2020-2025) & (US$ Million)
Table 11. Soliris (Eculizumab) Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Soliris (Eculizumab) Players by Revenue (US$ Million) in 2024
Table 13. Global Soliris (Eculizumab) Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Soliris (Eculizumab) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris (Eculizumab) as of 2024)
Table 15. Global Soliris (Eculizumab) Companies Headquarters
Table 16. Date of International Companies Enter into Soliris (Eculizumab) Market
Table 17. Global Soliris (Eculizumab) Companies Product & Service
Table 18. Global Soliris (Eculizumab) Mergers & Acquisitions, Expansion Plans
Table 19. Alexion Corporation Information
Table 20. Alexion Description and Business Overview
Table 21. Alexion Soliris (Eculizumab) Product
Table 22. Alexion Soliris (Eculizumab) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Alexion Revenue Proportion of Soliris (Eculizumab) by Product in 2024
Table 24. Alexion Revenue Proportion of Soliris (Eculizumab) by Application in 2024
Table 25. Alexion Revenue Proportion of Soliris (Eculizumab) by Geographic Area in 2024
Table 26. Alexion Recent Developments
Table 27. North America Soliris (Eculizumab) Revenue by Country (2020-2025) & (US$ Million)
Table 28. North America Soliris (Eculizumab) Revenue by Country (2026-2031) & (US$ Million)
Table 29. North America Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 30. North America Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 31. Asia-Pacific Soliris (Eculizumab) Revenue by Region (2020-2025) & (US$ Million)
Table 32. Asia-Pacific Soliris (Eculizumab) Revenue by Region (2026-2031) & (US$ Million)
Table 33. Asia-Pacific Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 34. Asia-Pacific Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 35. Europe Soliris (Eculizumab) Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Soliris (Eculizumab) Revenue by Country (2026-2031) & (US$ Million)
Table 37. Europe Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 38. Europe Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 39. Latin America Soliris (Eculizumab) Revenue by Country (2020-2025) & (US$ Million)
Table 40. Latin America Soliris (Eculizumab) Revenue by Country (2026-2031) & (US$ Million)
Table 41. Latin America Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 42. Latin America Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 43. Middle East and Africa Soliris (Eculizumab) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Middle East and Africa Soliris (Eculizumab) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Soliris (Eculizumab) Revenue by Type (2020-2025) & (US$ Million)
Table 46. Middle East and Africa Soliris (Eculizumab) Revenue by Application (2020-2025) & (US$ Million)
Table 47. Soliris (Eculizumab) Key Raw Materials, Industry Status and Trend
Table 48. Soliris (Eculizumab) Key Raw Materials and Upstream Suppliers
Table 49. Soliris (Eculizumab) Clients Status and Trend
Table 50. Soliris (Eculizumab) Typical Clients
Table 51. Soliris (Eculizumab) Distributors
Table 52. Soliris (Eculizumab) Market Trends
Table 53. Soliris (Eculizumab) Market Drivers
Table 54. Soliris (Eculizumab) Market Challenges
Table 55. Soliris (Eculizumab) Market Restraints
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Soliris (Eculizumab) Product Picture
Figure 2. Global Soliris (Eculizumab) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Soliris (Eculizumab) Revenue Market Share by Type in 2024 & 2031
Figure 4. Plasma Exchange Product Picture
Figure 5. Plasma Infusion Product Picture
Figure 6. Global Soliris (Eculizumab) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Soliris (Eculizumab) Revenue Market Share by Application in 2024 & 2031
Figure 8. PNH
Figure 9. aHUS
Figure 10. Others
Figure 11. Soliris (Eculizumab) Report Years Considered
Figure 12. Global Soliris (Eculizumab) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Soliris (Eculizumab) Market Size (2020-2031) & (US$ Million)
Figure 14. Global Soliris (Eculizumab) Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Soliris (Eculizumab) Revenue Market Share by Region (2020-2031)
Figure 16. Global Soliris (Eculizumab) Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Soliris (Eculizumab) Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Plasma Exchange of Soliris (Eculizumab) Revenue Market Share by Application, 2024 VS 2031
Figure 19. Plasma Infusion of Soliris (Eculizumab) Revenue Market Share by Application, 2024 VS 2031
Figure 20. Soliris (Eculizumab) Revenue Share by Company (2024)
Figure 21. Soliris (Eculizumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Plasma Exchange Revenue Proportion by Company in 2024
Figure 23. Plasma Infusion Revenue Proportion by Company in 2024
Figure 24. North America Soliris (Eculizumab) Revenue 2020-2031 (US$ Million)
Figure 25. North America Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 26. North America Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 27. Asia-Pacific Soliris (Eculizumab) Revenue 2020-2031 (US$ Million)
Figure 28. Asia-Pacific Soliris (Eculizumab) Revenue Market Share by Region (2020-2031)
Figure 29. Asia-Pacific Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 30. Asia-Pacific Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 31. Europe Soliris (Eculizumab) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 32. Europe Soliris (Eculizumab) Revenue Market Share by Country (2020-2031)
Figure 33. Europe Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 34. Europe Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 35. Latin America Soliris (Eculizumab) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Latin America Soliris (Eculizumab) Revenue Market Share by Country (2020-2031)
Figure 37. Latin America Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 38. Latin America Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 39. Middle East and Africa Soliris (Eculizumab) Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Country (2020-2031)
Figure 41. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Figure 42. Middle East and Africa Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Figure 43. Soliris (Eculizumab) Supply Chain (Upstream and Downstream Market)
Figure 44. Global Production Market Share of Soliris (Eculizumab) Raw Materials by Region in 2024
Figure 45. Soliris (Eculizumab) Distribution Channels
Figure 46. Global Soliris (Eculizumab) Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 47. Global Soliris (Eculizumab) Percentage 2020-2031: Online Sales VS Offline Sales
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232